Catalyst Wire Dossier Catalyst Wire Dossier

Ad5 vector COVID-19 vaccine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ad5 vector COVID-19 vaccine, covering 2022-04-06 to 2022-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Study on Heterologous Prime-boost of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine [Phase 4]

See pricing